{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:43:12Z","timestamp":1786977792413,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>The recent addition of immunoglobulin (Ig)G4-associated cholangitis (IAC), also called IgG4-related sclerosing cholangitis (IRSC), to the spectrum of chronic cholangiopathies has created the clinical need for reliable methods to discriminate between IAC and the more common cholestatic entities, primary (PSC) and secondary sclerosing cholangitis. The current American Association for the Study of Liver Diseases practice guidelines for PSC advise on the measurement of specific Ig (sIg)G4 in PSC patients, but interpretation of elevated sIgG4 levels remains unclear. We aimed to provide an algorithm to distinguish IAC from PSC using sIgG analyses. We measured total IgG and IgG subclasses in serum samples of IAC (n = 73) and PSC (n = 310) patients, as well as in serum samples of disease controls (primary biliary cirrhosis; n = 22). sIgG4 levels were elevated above the upper limit of normal (ULN = &gt;1.4 g\/L) in 45 PSC patients (15%; 95% confidence interval [CI]: 11-19). The highest specificity and positive predictive value (PPV; 100%) for IAC were reached when applying the 4\u00d7 ULN (sIgG4 &gt; 5.6 g\/L) cutoff with a sensitivity of 42% (95% CI: 31-55). However, in patients with a sIgG4 between 1\u00d7 and 2\u00d7 ULN (n = 38\/45), the PPV of sIgG4 for IAC was only 28%. In this subgroup, the sIgG4\/sIgG1 ratio cutoff of 0.24 yielded a sensitivity of 80% (95% CI: 51-95), a specificity of 74% (95% CI: 57-86), a PPV of 55% (95% CI: 33-75), and a negative predictive value of 90% (95% CI: 73-97).<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion :<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Elevated sIgG4 (&gt;1.4 g\/L) occurred in 15% of patients with PSC. In patients with a sIgG4 &gt;1.4 and &lt;2.8 g\/L, incorporating the IgG4\/IgG1 ratio with a cutoff at 0.24 in the diagnostic algorithm significantly improved PPV and specificity. We propose a new diagnostic algorithm based on IgG4\/IgG1 ratio that may be used in clinical practice to distinguish PSC from IAC. (Hepatology 2014;59:1954\u20131963)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.26977","type":"journal-article","created":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T00:41:19Z","timestamp":1387586479000},"page":"1954-1963","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":169,"title":["Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis"],"prefix":"10.1097","volume":"59","author":[{"given":"Kirsten","family":"Boonstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Maillette","family":"de Buy Wenniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne J.","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel J.","family":"van Erpecum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Poen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.J.","family":"van Nieuwkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel B.W.","family":"Spanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.M.","family":"Witteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans A.R.E.","family":"Tuynman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"van Geloven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y.","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20250207","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"R2-35-20250207","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1478-3231.2011.02607.x","article-title":"Evolving concepts in primary sclerosing cholangitis.","volume":"32","author":"Krones","year":"2012","journal-title":"Liver Int"},{"key":"R3-35-20250207","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Populationbased epidemiology, malignancy risk and outcome of primary sclerosing cholangitis.","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"R4-35-20250207","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis.","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"R5-35-20250207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases.","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"R6-35-20250207","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4related disease and its individual organ system manifestations.","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R7-35-20250207","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4associated cholangitis: clinical profile and response to therapy.","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"R8-35-20250207","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","article-title":"Autoimmune pancreatitis and IgG4related sclerosing disease.","volume":"7","author":"Kamisawa","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-35-20250207","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jclinpath-2012-200932","article-title":"IgG4related disease: can nonclassical histopathological features or the examination of clinically uninvolved tissues be helpful in the diagnosis?","volume":"65","author":"Culver","year":"2012","journal-title":"J Clin Pathol"},{"key":"R10-35-20250207","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4related disease.","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R11-35-20250207","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4related disease.","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"R12-35-20250207","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody.","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"R13-35-20250207","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis.","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R14-35-20250207","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","article-title":"Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinics HISORt criteria.","volume":"42","author":"Chari","year":"2007","journal-title":"J Gastroenterol"},{"key":"R15-35-20250207","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000213364","article-title":"Immunoglobulin G4associated cholangitis: one variant of immunoglobulin G4related systemic disease.","volume":"79","author":"Alderlieste","year":"2009","journal-title":"Digestion"},{"key":"R16-35-20250207","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0031-1291540","article-title":"What an endoscopist should know about immunoglobulinG4associated disease of the pancreas and biliary tree.","volume":"44","author":"Maillette de Buy Wenniger","year":"2012","journal-title":"Endoscopy"},{"key":"R17-35-20250207","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00535-007-2038-8","article-title":"Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.","volume":"42","author":"Nishino","year":"2007","journal-title":"J Gastroenterol"},{"key":"R18-35-20250207","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R19-35-20250207","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R20-35-20250207","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4 plasma cell infiltrates in liver explants with primary sclerosing cholangitis.","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R21-35-20250207","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to therapy.","volume":"18","author":"Bjornsson","year":"2011","journal-title":"Am J Ther"},{"key":"R22-35-20250207","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0030-1256872","article-title":"Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4associated cholangiopathy.","volume":"44","author":"Vosskuhl","year":"2012","journal-title":"Endoscopy"},{"key":"R23-35-20250207","doi-asserted-by":"crossref","first-page":"32574","DOI":"10.5402\/2012\/325743","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobuling4: a preliminary study.","volume":"2012","author":"Parhizkar","year":"2012","journal-title":"ISRN Gastroenterol"},{"key":"R24-35-20250207","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"IgG4 clones identified by nextgeneration sequencing dominate the bcell receptor repertoire in IgG4associated cholangitis.","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"key":"R25-35-20250207","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0006-341X.2000.00345.x","article-title":"Comparisons of predictive values of binary medical diagnostic tests for paired designs.","volume":"56","author":"Leisenring","year":"2000","journal-title":"Biometrics"},{"key":"R27-35-20250207","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jgh.12248","article-title":"Establishment of a serum IgG4 cutoff value for the differential diagnosis of IgG4related sclerosing cholangitisa japanese cohort.","volume":"28","author":"Ohara","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R28-35-20250207","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4associated cholangitis from cholangiocarcinoma.","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"key":"R29-35-20250207","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/j.semdp.2012.07.005","article-title":"Immunoglobulin G4related sclerosing cholangitis: pathologic features and histologic mimics.","volume":"29","author":"Zen","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"R30-35-20250207","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.12120224","article-title":"Findings of the UK national audit evaluating imageguided or imageassisted liver biopsy. Part II. Minor and major complications and procedurerelated mortality.","volume":"266","author":"Howlett","year":"2013","journal-title":"Radiology"},{"key":"R31-35-20250207","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis.","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"R32-35-20250207","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.286.6370.1015-a","article-title":"Predominance of IgG3 subclass in primary biliary cirrhosis.","volume":"286","author":"Riggione","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R33-35-20250207","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies crossreactive with the major mitochondrial autoepitope and its Lactobacillus mimic.","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"R34-35-20250207","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26977","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.26977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.26977","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201405000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:57:22Z","timestamp":1738929442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201405000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26977","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}